BreezeMeds
BreezeMeds is a telehealth platform that offers both injectable and oral compounded GLP-1 formulations — a combination that most competitors do not provide. The platform serves all 50 states with an online-only consultation process, and distinguishes itself through named physician leadership and published pharmacy partnerships.
Overview
- Consultation Model
- Async Telehealth
- Headquarters
- United States
- Shipping
- 3-5 business days
- Lab Testing
- No
- Prescriber Info
- licensed provider reviews your submission 3.
Pros
- Oral formulations for both semaglutide and tirzepatide
- Named physician leadership (Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD)
- Four named pharmacy partners
- All 50 states served
- 24/7 support and coaching
- FSA/HSA eligible
Cons
- 2–3 week delivery timeline is significantly slower than most competitors (~1 week)
- All medications are compounded
- Compounded GLP-1s face active FDA enforcement pressure; supply and legal landscape can change
- Oral semaglutide ($299/mo) and oral tirzepatide ($399/mo) are among the most expensive options in the compounded market
- Injectable tirzepatide pricing not prominently published
- Cash-pay only; no insurance pathway
Pricing
| Medication | Dose | Price | Billing |
|---|---|---|---|
| semaglutide | standard | $199 | monthly |